VINS Bioproducts completes phase-II clinical trials for COVID-19 antidote VINCOV-19
VINCOV-19 is now ready for market authorisation and for simultaneous phase-III clinical trials
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Centre for Cellular and Molecular Biology
Thermo Fisher Scientific’s cryo-electron microscopy solutions to help drive groundbreaking…
The facility will be accessible to researchers in CCMB, and other CSIR labs as well as researchers from other institutes,…
Scientists to culture novel coronavirus in human lung epithelial cell
It will enable in vitro testing of potential drugs and vaccines against COVID-19